論文

査読有り 最終著者 責任著者
2021年7月7日

Visualizing Neuropharmacological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder Using Functional Near-Infrared Spectroscopy

Frontiers in Neuroergonomics
  • Takahiro Ikeda
  • Akari Inoue
  • Daisuke Tanaka
  • Tamao Hashimoto
  • Stephanie Sutoko
  • Tatsuya Tokuda
  • Yasushi Kyutoku
  • Atsushi Maki
  • Takanori Yamagata
  • Ippeita Dan
  • Yukifumi Monden
  • 全て表示

2
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.3389/fnrgo.2021.657657
出版者・発行元
Frontiers Media SA

<jats:p><jats:bold>Objective:</jats:bold> In the current study, we explored the neural substrate for acute effects of guanfacine extended release (GXR) on inhibitory control in school-aged children with attention deficit hyperactivity disorder (ADHD), using functional near-infrared spectroscopy (fNIRS).</jats:p><jats:p><jats:bold>Methods:</jats:bold> Following a GXR washout period, 12 AD HD children (6–10 years old) performed a go/no-go task before and 3 h after GXR or placebo administration, in a randomized, double-blind, placebo-controlled, crossover design study. In the primary analysis, fNIRS was used to monitor the right prefrontal cortical hemodynamics of the participants, where our former studies showed consistent dysfunction and osmotic release oral system-methylphenidate (OROS-MPH) and atomoxetine hydrochloride (ATX) elicited recovery. We examined the inter-medication contrast, comparing the effect of GXR against the placebo. In the exploratory analysis, we explored neural responses in regions other than the right prefrontal cortex (PFC).</jats:p><jats:p><jats:bold>Results:</jats:bold> In the primary analysis, we observed no significant main effects or interactions of medication type and age in month (two-way mixed ANCOVA, <jats:italic>Fs</jats:italic> &lt; 0.20, all <jats:italic>ps</jats:italic> &gt; .05). However, in the <jats:italic>post-hoc</jats:italic> analysis, we observed significant change in the oxy-Hb signal in the right angular gyrus (AG) for inter-medication (one sample <jats:italic>t</jats:italic>-test, <jats:italic>p</jats:italic> &lt; 0.05, uncorrected, Cohen's <jats:italic>d</jats:italic> = 0.71).</jats:p><jats:p><jats:bold>Conclusions:</jats:bold> These results are different from the neuropharmacological effects of OROS-MPH and ATX, which, in an upregulated manner, reduced right PFC function in ADHD children during inhibitory tasks. This analysis, while limited by its secondary nature, suggested that the improved cognitive performance was associated with activation in the right AG, which might serve as a biological marker to monitor the effect of GXR in the ADHD children.</jats:p>

リンク情報
DOI
https://doi.org/10.3389/fnrgo.2021.657657
CiNii Research
https://cir.nii.ac.jp/crid/1360294643746267776?lang=ja
共同研究・競争的資金等の研究課題
光トポグラフィー検査を用いたAD/HDに対するグアンファシン(GXR)の脳機能学的薬理作用の可視化
URL
https://www.frontiersin.org/articles/10.3389/fnrgo.2021.657657/full
ID情報
  • DOI : 10.3389/fnrgo.2021.657657
  • eISSN : 2673-6195
  • CiNii Research ID : 1360294643746267776

エクスポート
BibTeX RIS